These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26481465)

  • 1. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
    Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
    Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
    Winther M; Alsner J; Tramm T; Nordsmark M
    Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
    Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
    Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.
    Yang PW; Huang YC; Hsieh CY; Hua KT; Huang YT; Chiang TH; Chen JS; Huang PM; Hsu HH; Kuo SW; Kuo ML; Lee JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S601-9. PubMed ID: 24770678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
    Tanaka K; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S607-15. PubMed ID: 23838916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China.
    He Y; Jin J; Wang L; Hu Y; Liang D; Yang H; Liu Y; Shan B
    Clin Exp Metastasis; 2017 Jan; 34(1):73-84. PubMed ID: 27885434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.
    Ren C; Chen H; Han C; Fu D; Zhou L; Jin G; Wang F; Wang D; Chen Y; Ma L; Zheng X; Han D
    Oncotarget; 2016 Mar; 7(13):15840-53. PubMed ID: 26895105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
    Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
    J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction.
    Odenthal M; Hee J; Gockel I; Sisic L; Schmitz J; Stoecklein NH; Driemel C; Möhlendick B; Schmidt T; Knoefel WT; Lang H; Büttner R; Ott K; Vallböhmer D
    Int J Cancer; 2015 Jul; 137(1):230-7. PubMed ID: 25429911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer.
    Muijs C; Smit J; Karrenbeld A; Beukema J; Mul V; van Dam G; Hospers G; Kluin P; Langendijk J; Plukker J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):845-52. PubMed ID: 24411191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
    Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y
    Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
    Wu X; Gu J; Wu TT; Swisher SG; Liao Z; Correa AM; Liu J; Etzel CJ; Amos CI; Huang M; Chiang SS; Milas L; Hittelman WN; Ajani JA
    J Clin Oncol; 2006 Aug; 24(23):3789-98. PubMed ID: 16785472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing.
    Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ
    Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.